Logo image of AMBI

AMBIPAR EMERGENCY RESPONSE (AMBI) Stock Fundamental Analysis

NYSEARCA:AMBI - NYSE Arca - KYG025321020 - Common Stock - Currency: USD

4.47  +0.13 (+3%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMBI. AMBI was compared to 83 industry peers in the Commercial Services & Supplies industry. While AMBI seems to be doing ok healthwise, there are quite some concerns on its profitability. AMBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AMBI had positive earnings in the past year.
In the past year AMBI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AMBI reported negative net income in multiple years.
In multiple years AMBI reported negative operating cash flow during the last 5 years.
AMBI Yearly Net Income VS EBIT VS OCF VS FCFAMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 200M 400M

1.2 Ratios

AMBI has a Return On Assets (0.93%) which is in line with its industry peers.
AMBI has a Return On Equity (3.62%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 9.19%, AMBI is in the better half of the industry, outperforming 73.49% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMBI is in line with the industry average of 10.57%.
Industry RankSector Rank
ROA 0.93%
ROE 3.62%
ROIC 9.19%
ROA(3y)4.14%
ROA(5y)N/A
ROE(3y)26.2%
ROE(5y)N/A
ROIC(3y)9.89%
ROIC(5y)N/A
AMBI Yearly ROA, ROE, ROICAMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

AMBI has a Profit Margin (1.53%) which is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 16.79%, AMBI belongs to the top of the industry, outperforming 84.34% of the companies in the same industry.
The Gross Margin of AMBI (17.67%) is worse than 77.11% of its industry peers.
Industry RankSector Rank
OM 16.79%
PM (TTM) 1.53%
GM 17.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMBI Yearly Profit, Operating, Gross MarginsAMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 5 10 15 20

4

2. Health

2.1 Basic Checks

AMBI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMBI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, AMBI has an improved debt to assets ratio.
AMBI Yearly Shares OutstandingAMBI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M 50M
AMBI Yearly Total Debt VS Total AssetsAMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

AMBI has an Altman-Z score of 1.36. This is a bad value and indicates that AMBI is not financially healthy and even has some risk of bankruptcy.
AMBI has a worse Altman-Z score (1.36) than 69.88% of its industry peers.
The Debt to FCF ratio of AMBI is 9.96, which is on the high side as it means it would take AMBI, 9.96 years of fcf income to pay off all of its debts.
AMBI has a Debt to FCF ratio (9.96) which is in line with its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that AMBI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.93, AMBI is doing worse than 78.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 9.96
Altman-Z 1.36
ROIC/WACC0.73
WACC12.55%
AMBI Yearly LT Debt VS Equity VS FCFAMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

AMBI has a Current Ratio of 2.07. This indicates that AMBI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.07, AMBI is doing good in the industry, outperforming 73.49% of the companies in the same industry.
AMBI has a Quick Ratio of 1.97. This is a normal value and indicates that AMBI is financially healthy and should not expect problems in meeting its short term obligations.
AMBI has a Quick ratio of 1.97. This is amongst the best in the industry. AMBI outperforms 81.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.97
AMBI Yearly Current Assets VS Current LiabilitesAMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 500M 1B

1

3. Growth

3.1 Past

AMBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -138.69%.
Looking at the last year, AMBI shows a very strong growth in Revenue. The Revenue has grown by 53.72%.
EPS 1Y (TTM)-138.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.37%
Revenue 1Y (TTM)53.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%57.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBI Yearly Revenue VS EstimatesAMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 500M 1B 1.5B 2B 2.5B

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.80 indicates a quite expensive valuation of AMBI.
AMBI's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of AMBI to the average of the S&P500 Index (24.21), we can say AMBI is valued slightly more expensively.
Industry RankSector Rank
PE 29.8
Fwd PE N/A
AMBI Price Earnings VS Forward Price EarningsAMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMBI is valued cheaply inside the industry as 90.36% of the companies are valued more expensively.
96.39% of the companies in the same industry are more expensive than AMBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.17
EV/EBITDA 4.39
AMBI Per share dataAMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMBIPAR EMERGENCY RESPONSE

NYSEARCA:AMBI (5/9/2025, 8:04:02 PM)

4.47

+0.13 (+3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.71%
Inst Owner Change-0.2%
Ins Owners1.68%
Ins Owner ChangeN/A
Market Cap247.77M
AnalystsN/A
Price TargetN/A
Short Float %0.55%
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.8
Fwd PE N/A
P/S 0.45
P/FCF 5.17
P/OCF 3.63
P/B 1.06
P/tB N/A
EV/EBITDA 4.39
EPS(TTM)0.15
EY3.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.86
FCFY19.33%
OCF(TTM)1.23
OCFY27.56%
SpS9.96
BVpS4.21
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.62%
ROCE 12.09%
ROIC 9.19%
ROICexc 10.17%
ROICexgc 20.1%
OM 16.79%
PM (TTM) 1.53%
GM 17.67%
FCFM 8.68%
ROA(3y)4.14%
ROA(5y)N/A
ROE(3y)26.2%
ROE(5y)N/A
ROIC(3y)9.89%
ROIC(5y)N/A
ROICexc(3y)10.24%
ROICexc(5y)N/A
ROICexgc(3y)23.5%
ROICexgc(5y)N/A
ROCE(3y)12.99%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 9.96
Debt/EBITDA 3.23
Cap/Depr 43.69%
Cap/Sales 3.69%
Interest Coverage 4.15
Cash Conversion 49.01%
Profit Quality 566.61%
Current Ratio 2.07
Quick Ratio 1.97
Altman-Z 1.36
F-Score4
WACC12.55%
ROIC/WACC0.73
Cap/Depr(3y)141.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-138.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)53.72%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%57.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-143.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.34%
OCF growth 3YN/A
OCF growth 5YN/A